{"componentChunkName":"component---src-templates-topic-topic-tsx","path":"/topics/fungal-skin-infection-foot/","result":{"data":{"firstChapter":{"id":"66fe4516-176d-5ffc-aebd-99a58afbd57c","slug":"summary","fullItemName":"Summary","subChapters":[],"depth":1,"htmlHeader":"<!-- begin field 0df1b2a0-f332-439f-9bf9-140430fc1c6c --><h1>Fungal skin infection - foot: Summary</h1><!-- end field 0df1b2a0-f332-439f-9bf9-140430fc1c6c -->","htmlStringContent":"<!-- begin item 52f7875e-47c6-4bff-8b6f-8f916b41253c --><!-- begin field c4cd37ec-f287-4a5f-a6f5-1eb9a1b89452 --><ul><li>Fungal infection of the foot is also known as 'athlete's foot' or 'tinea pedis', and it describes superficial skin infection of the feet and toes, predominantly caused by dermatophytes. Different sub-types include:<ul><li>Interdigital — most common; affects the lateral toe web spaces first; usually caused by <em>Trichophyton rubrum</em>.</li><li>Moccasin or dry — diffuse chronic scaling and hyperkeratosis affecting the sole and lateral foot; usually caused by <em>Trichophyton rubrum</em>.</li><li>Vesicobullous — least common; multiple small vesicles and blisters mainly on the arches and soles of the feet; usually caused by <em>Trichophyton interdigitale</em>.</li></ul></li><li>Risk factors for acquiring infection include hot, humid climates or working environments; occlusive footwear; hyperhidrosis; walking on contaminated surfaces; and immunocompromised states.</li><li>Infection is common in adolescents but rare in pre-pubertal children.</li><li>The diagnosis of suspected fungal foot infection should be made on the basis of clinical features which allows classification into different sub-types. There may be a history of itchy, flaky, or painful skin of the feet.</li><li>Assessment of suspected fungal foot infection should include:<ul><li>Asking about the nature, site, and duration of symptoms; previous treatments; close contacts; co-morbidities.</li><li>Examining the pattern, extent, and severity of infection, and for any associated inflammation or fungal infection at other sites.</li><li>Arranging for skin sampling for fungal microscopy and culture if there is severe or extensive disease in adults, or the diagnosis is uncertain.</li></ul></li><li>Initial management of fungal foot infection should include:<ul><li>Advice on self-care strategies and sources of information.</li><li>Advice on treatment with a topical antifungal cream such as terbinafine, an imidazole, undecenoic acid, or topical preparations containing tolnaftate, if there is mild, non-extensive disease in children and adults.</li><li>Prescribing a short-term mildly-potent topical corticosteroid such as hydrocortisone cream in addition, if there is associated marked inflammation.</li><li>Considering prescribing an oral antifungal such as terbinafine first-line if an adult has severe or extensive disease, depending on fungal microscopy or culture results and/or clinical judgement. Alternative options are oral itraconazole or oral griseofulvin, if terbinafine is not tolerated or is contraindicated.</li><li>Managing concomitant fungal nail, hand, or groin infection, if present, to reduce the risk of reinfection.</li></ul></li><li>If there are persistent signs of infection following topical antifungal treatment in adults:<ul><li>Any underlying cause of treatment failure should be managed, such as non-adherence to self-care advice or the treatment regimen; or reinfection from close contacts.</li><li>Skin sampling for fungal microscopy and culture should be arranged.</li><li>Oral antifungal treatment should be prescribed depending on microscopy or culture results and/or clinical judgement.</li></ul></li><li>Referral to a dermatology specialist should be arranged, the urgency depending on clinical judgement, if:<ul><li>There is severe or extensive disease, or topical antifungal treatment is unsuccessful in a child.</li><li>The diagnosis is uncertain.</li><li>Treatment in primary care is unsuccessful.</li><li>The person is immunocompromised, depending on clinical judgement.</li></ul></li></ul><!-- end field c4cd37ec-f287-4a5f-a6f5-1eb9a1b89452 --><!-- end item 52f7875e-47c6-4bff-8b6f-8f916b41253c -->","topic":{"id":"32650c82-f347-5933-adc6-d0da00f3d764","topicId":"35b0fa0c-8988-453f-af54-60cd595d29ad","topicName":"Fungal skin infection - foot","slug":"fungal-skin-infection-foot","aliases":[],"chapters":[{"id":"66fe4516-176d-5ffc-aebd-99a58afbd57c","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"5231c18b-820c-586e-87f0-5527574f70d1","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"e2b3169b-582d-5dda-b94f-73ccd139eede","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"8e1fd155-8f48-5bf7-a40c-4d2931a41736","slug":"changes","fullItemName":"Changes"},{"id":"8249fd1f-7c27-535b-a721-9e280d761ea5","slug":"update","fullItemName":"Update"}]},{"id":"e4ea5f16-99ef-5247-87e9-141b06d8b21a","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"524d92eb-2792-5543-a6d9-78e4f825cf22","slug":"goals","fullItemName":"Goals"},{"id":"a678e6e3-5a4b-55cb-b7d6-c6ab9580eda2","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"44708a93-b41d-5827-9293-650b191df0b0","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"5d578224-3b80-58f6-9894-5c90e41c1b44","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"a029f7b6-3344-51e6-ab22-bafdf196a4b7","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"b487a461-1526-54bb-a2df-4e2e0562293d","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"0e034d35-5e8d-5db3-a518-77103caa73c8","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"73e18fb0-6f03-51ed-bddf-355959375e75","slug":"definition","fullItemName":"Definition"},{"id":"a33dea25-362f-5128-9c14-d178ef837bfe","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"a4167228-e44b-560b-8406-20294a5b8e42","slug":"prevalence","fullItemName":"Prevalence"},{"id":"91f3fb6f-6926-547c-830c-dd963749fb55","slug":"complications","fullItemName":"Complications"},{"id":"8373f46b-763e-53e3-9ea8-90cd767d66e6","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"090da929-a640-586e-a803-a47b38656e1d","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"024c307f-3650-539d-b0b4-4f1c4a8db49e","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"e3544fc8-cba9-524d-aed2-f28ae6f802e8","slug":"assessment","fullItemName":"Assessment"},{"id":"3ad14837-2b4c-58ab-b5c5-456d63d403ae","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"db051fa9-f61e-5787-bd5d-b2ff4a77ba85","slug":"management","fullItemName":"Management","subChapters":[{"id":"a11a4a32-6cc1-5c40-8396-099a218e1487","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"d96bb08c-b21d-517b-830e-ead35a26fe8e","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"27a2a883-b20f-5b25-825b-3bc5b02c1f77","slug":"topical-antifungals","fullItemName":"Topical antifungals"},{"id":"476702d7-9e1a-5dfd-b3b0-899ebce5130b","slug":"oral-terbinafine","fullItemName":"Oral terbinafine"},{"id":"e3c1f25f-1a76-53af-aef4-b39eecdf04d7","slug":"oral-itraconazole","fullItemName":"Oral itraconazole"},{"id":"4f73cab3-f311-54bd-beac-8bb860f26e2f","slug":"oral-griseofulvin","fullItemName":"Oral griseofulvin"}]},{"id":"aaec6565-5327-5bd4-bc06-a1442065c1bd","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"c64c0494-1e71-5960-a8c9-a05141d2801c","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"265ba112-5e5e-59c8-8569-29d1a263263d","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"e7088451-abf0-5e2f-a546-109de8062cbf","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"96559e5f-dca9-5c90-af8c-c1182e5d3306","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"bd075cd9-9444-5680-bd23-a168ebe2b5a2","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"49b473c6-a745-5480-9602-1224549611f7","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"65b0f432-1967-593c-a9f7-2326776f4e83","slug":"references","fullItemName":"References","subChapters":[]}]}},"topic":{"id":"32650c82-f347-5933-adc6-d0da00f3d764","topicId":"35b0fa0c-8988-453f-af54-60cd595d29ad","topicName":"Fungal skin infection - foot","slug":"fungal-skin-infection-foot","aliases":[],"topicSummary":"Fungal infection of the foot (athlete's foot or tinea pedis) is a skin infection of the feet and toes, predominantly caused by dermatophytes","lastRevised":"Last revised in April 2018","nextPlannedReviewBy":"2023-04-01T00:00:00+01:00","nextPlannedReviewByDateTime":"2023-03","nextPlannedReviewByDisplay":"March 2023","specialities":[{"id":"e174a859-759f-5b1d-898e-1a4155645e13","name":"Infections and infestations","slug":"infections-infestations"},{"id":"50071c38-ab10-5ab8-ac70-6bd19a96c24e","name":"Skin and nail","slug":"skin-nail"}],"chapters":[{"id":"66fe4516-176d-5ffc-aebd-99a58afbd57c","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"5231c18b-820c-586e-87f0-5527574f70d1","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"e2b3169b-582d-5dda-b94f-73ccd139eede","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"8e1fd155-8f48-5bf7-a40c-4d2931a41736","slug":"changes","fullItemName":"Changes"},{"id":"8249fd1f-7c27-535b-a721-9e280d761ea5","slug":"update","fullItemName":"Update"}]},{"id":"e4ea5f16-99ef-5247-87e9-141b06d8b21a","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"524d92eb-2792-5543-a6d9-78e4f825cf22","slug":"goals","fullItemName":"Goals"},{"id":"a678e6e3-5a4b-55cb-b7d6-c6ab9580eda2","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"44708a93-b41d-5827-9293-650b191df0b0","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"5d578224-3b80-58f6-9894-5c90e41c1b44","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"a029f7b6-3344-51e6-ab22-bafdf196a4b7","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"b487a461-1526-54bb-a2df-4e2e0562293d","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"0e034d35-5e8d-5db3-a518-77103caa73c8","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"73e18fb0-6f03-51ed-bddf-355959375e75","slug":"definition","fullItemName":"Definition"},{"id":"a33dea25-362f-5128-9c14-d178ef837bfe","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"a4167228-e44b-560b-8406-20294a5b8e42","slug":"prevalence","fullItemName":"Prevalence"},{"id":"91f3fb6f-6926-547c-830c-dd963749fb55","slug":"complications","fullItemName":"Complications"},{"id":"8373f46b-763e-53e3-9ea8-90cd767d66e6","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"090da929-a640-586e-a803-a47b38656e1d","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"024c307f-3650-539d-b0b4-4f1c4a8db49e","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"e3544fc8-cba9-524d-aed2-f28ae6f802e8","slug":"assessment","fullItemName":"Assessment"},{"id":"3ad14837-2b4c-58ab-b5c5-456d63d403ae","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"db051fa9-f61e-5787-bd5d-b2ff4a77ba85","slug":"management","fullItemName":"Management","subChapters":[{"id":"a11a4a32-6cc1-5c40-8396-099a218e1487","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"d96bb08c-b21d-517b-830e-ead35a26fe8e","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"27a2a883-b20f-5b25-825b-3bc5b02c1f77","slug":"topical-antifungals","fullItemName":"Topical antifungals"},{"id":"476702d7-9e1a-5dfd-b3b0-899ebce5130b","slug":"oral-terbinafine","fullItemName":"Oral terbinafine"},{"id":"e3c1f25f-1a76-53af-aef4-b39eecdf04d7","slug":"oral-itraconazole","fullItemName":"Oral itraconazole"},{"id":"4f73cab3-f311-54bd-beac-8bb860f26e2f","slug":"oral-griseofulvin","fullItemName":"Oral griseofulvin"}]},{"id":"aaec6565-5327-5bd4-bc06-a1442065c1bd","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"c64c0494-1e71-5960-a8c9-a05141d2801c","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"265ba112-5e5e-59c8-8569-29d1a263263d","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"e7088451-abf0-5e2f-a546-109de8062cbf","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"96559e5f-dca9-5c90-af8c-c1182e5d3306","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"bd075cd9-9444-5680-bd23-a168ebe2b5a2","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"49b473c6-a745-5480-9602-1224549611f7","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"65b0f432-1967-593c-a9f7-2326776f4e83","slug":"references","fullItemName":"References","subChapters":[]}]}},"pageContext":{"id":"32650c82-f347-5933-adc6-d0da00f3d764"}},"staticQueryHashes":["3666801979"]}